Quantitative Determination of the Volume of Suspension Delivered Via the Uniject Delivery System Following Simulated Subcutaneous Injection by Healthcare Professionals Into a Synthetic Subcutaneous Injection Training Device
The purpose of this study is to determine the volumetric delivery of the Uniject.
Observe subjects deliver the drug None used
Time Perspective: Prospective
Target Follow-Up Duration
single use container
Intervention: Other: Uniject
* Includes publications given by the data provider as well as publications
identified by ClinicalTrials.gov Identifier (NCT Number) in Medline.
Primary Completion Date
June 2010 (Final data collection date for primary outcome measure)
Sexes Eligible for Study:
18 Years to 65 Years (Adult)
Accepts Healthy Volunteers
Contact information is only displayed when the study is recruiting subjects
Listed Location Countries
Removed Location Countries
Other Study ID Numbers
Has Data Monitoring Committee
U.S. FDA-regulated Product
IPD Sharing Statement
Director, Clinical Trial Disclosure Group, Pfizer, Inc.
Pfizer CT.gov Call Center
FOR MORE INFORMATION
Contact a representative by phone, email, or visiting thte study website. To get updates and notications about this trail, sign up using the form below.